# Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer

> **NCT03944265** · NA · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 14 (actual)

## Conditions studied

- Activating ALK Gene Mutation Negative
- Activating EGFR Gene Mutation Negative
- Activating ROS1 Gene Mutation Negative
- Health Care Provider
- Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Stage IVA Lung Cancer AJCC v8
- Stage IVB Lung Cancer AJCC v8

## Interventions

- **OTHER:** Counseling
- **OTHER:** Questionnaire Administration
- **OTHER:** Medical Chart Review

## Key facts

- **NCT ID:** NCT03944265
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-08
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03944265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03944265, "Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03944265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*